#CoverCannabis

Drug overdose deaths in 2020 hit highest number ever recorded, CDC data shows

New data released by the CDC has revealed that drug overdose deaths rose by close to 30% in the United States in 2020 – hitting the highest number ever recorded. As in recent years, inappropriate use of opioids was behind most of the deaths. Overdoses from opioids have been steadily worsening in the US for decades. Congress has blamed the FDA for approving new synthetic opioids and some drug-makers have been prosecuted for their role in marketing them. Doctors have also been blamed for overprescribing opioids and addicting people to them in the first place.

When are we going to stop talking about “what needs to be done” and actually introduce some bold changes here!? Sure, the FDA could introduce more oversight in prescribing – but you can’t take something away without empowering doctors with a safe and effective alternative. I won’t claim that cannabinoid-based medicine will solve this complex problem – but the fact that new doctors are graduating med school with zero knowledge about this much safer class of medicine and the majority of veteran doctors are still dismissive, is unacceptable and untenable given the evidence—especially when it comes to managing pain.

In the fight against opioid addiction we need to equip medical professionals with knowledge regarding safer alternatives AND improve patient access by providing more robust cost coverage.

The #CoverCannabis Project: Meet Sharon

Meet Sharon. She’s been struggling with IBS, insomnia and chronic pain for far too long. Medical Cannabis has been a game-changer for her quality of life, but like so many seniors on a fixed income, the cost is a strain. Please share & tag your local MP/MPPs if you support more coverage for medical cannabis. We can’t get this done without you!

The #CoverCannabis Project: Meet Sharon

Meet Sharon. She’s been struggling with IBS, insomnia and chronic pain for far too long. Medical Cannabis has been a game-changer for her quality of life, but like so many seniors on a fixed income, the cost is a strain. Please share & tag your local MP/MPPs if you support more coverage for medical cannabis. We can’t get this done without you!

The #CoverCannabis Project: Janet's Story

Need another reason why medicinal cannabis should be covered? Take a look at this amazing story. After just a couple of weeks on cannabinoid therapy, my patient has her severe fibromyalgia and osteoarthritis pain under control and has been able to sleep through the night for the first time in NINE years! You’ve heard me say it a million times, but a good night’s sleep goes a long way in reducing pain. Oh and we’ve been able to wean her opioid pain medication too.

Grateful to all my patients who have shared their story to further this important cause: #CoverCannabis

CBD Reduces Plaque, Improves Cognitive Function in Model of Familial Alzheimer's

There is a dire need for novel therapies to improve outcomes for patients with Alzheimer’s Disease, which is considered one of the fastest-growing health threats of our time.

In a promising new study published in the Journal of Alzheimer’s Disease, investigators reported that a two-week course of high dose CBD helped reduce plaque and improve cognitive function in an experimental model of early onset familial AD.

Familial disease is an inherited version of Alzheimer’s in which symptoms typically surface in the 30s and 40s and occurs in about 10-15% of patients.

Next steps include determining optimal doses and giving CBD earlier in the disease process. They also are exploring delivery systems including the use of an inhaler that should help deliver the CBD more directly to the brain.

See article below for more information. https://www.sciencedaily.com/releases/2021/03/210309192548.htm Citation for journal article, available here https://pubmed.ncbi.nlm.nih.gov/33612548/

Continuing the Conversation: Medical Cannabis in Long-Term Care

I wanted to continue the conversation about cannabinoid therapy in long term care this week by sharing some insights from my colleague Kim Van Dam, Administrator at Steeves & Rozema’s Trillium Villa.

Here she talks about the outcomes we’ve seen in successfully reducing narcotic and antipsychotic use amongst residents living with chronic pain and dementia.

Trillium Villa is one of Ontario’s first LTC residences to introduce cannabinoid therapy and the first home that I worked in several years ago. I continue to work with Kim and the forward-thinking & dedicated S&R team to this day and have been excited by the number of like-minded long term care organizations and in-house physicians who have reached out to learn more about whether it could benefit their residents/patients.

Medical Cannabis and Long-Term Care

When assessing under what circumstances the Government and private insurers should #CoverCannabis, residents living in long term care facilities would be a great place to start. These people have been through so much over the last year--particularly those living with dementia, as the prolonged isolation and disruption to their routines can lead to increased behavioural and psychological symptoms.

Medical cannabis offers a safe & effective multimodal medication that can improve quality of life amongst LTC residents in a range of medical scenarios, including dementia, chronic pain, insomnia and mental health--but the cost is precluding too many seniors from accessing this treatment. We must do better for our most vulnerable citizens.

Special thanks to my colleague Kelly Batson, Manager, Resident Care, Education and Operations at Steeves & Rozema’s Trillium Villa for her vision, leadership and sharing her experience.

The #CoverCannabis Project: The Sarnia Journal

“The unjust part of it is that we have guidelines to switch people off opiates, and patients want to do this. But when they have to choose between groceries or medication that is covered – but possibly more harmful – they usually go for the medication that’s covered.”

Huge thanks to the Sarnia Journal for helping to raise awareness of the #CoverCannabis movement. We’re really starting to gain some momentum and are grateful to everyone who is helping us spread the word and sharing their own stories. If you don’t feel comfortable sharing your experience on social, e-mail me at info@pearsonhealth.com and we can help you share it anonymously. These are the stories that will make change happen.

Full article available here.

The #CoverCannabis Project: Global News Interview with Patient Kelly

I challenge anyone to listen to my patient Kelly’s story and explain why her medical cannabis should not be covered. Full interview here: https://bit.ly/3ao2lPw

Kelly went from taking 17 drugs, including heavy narcotics like fentanyl, percocet, and oxycontin, sleeping pills like zopiclone, and biologic medications that suppress the immune system, to just her thyroid medication and her medical cannabis.

Not only is it much safer to be on fewer medications - there’s a huge cost benefit to insurers.

Cannabinoid therapy is saving Kelly’s private insurance provider thousands of dollars a year, now that she’s on SIXTEEN fewer covered meds. Not to mention the direct cost savings to #OHIP through reduced doctor visits and avoiding the hospital due to potential drug interactions. But despite all this, she has to pay out-of-pocket for the only therapy that has ever worked.

Someone please explain this to me. Or better yet, public and private policymakers, please contact me to shed some light on this for you. Truly - I’d be happy to collaborate with you.

The #CoverCannabis Project: Another Day, Another Patient Unable To Afford Medical Cannabis

Creative - 02.01.2021 (1).png

Another day, another e-mail from a patient who can no longer afford to continue on a medical treatment that is safer and more effective than anything else they’ve been on because they can’t afford it. This should make everyone who believes in universal healthcare furious.